Skip to main content

View full-text article in PMC

. 2012 Dec 19;7(12):e48291. doi: 10.1371/journal.pone.0048291

Table 3. A summary of the differential responses of MES-SA and MES-SA/DX5 cells to US treatment.

		Treatment
		Control	0.2 W/cm²	0.3 W/cm²	0.4 W/cm²	0.5 W/cm²
WST-8 Assay (%)	MES-AS	100.0±0.0	91.1±2.7	66.8±5.9^*	37.1±6.6	22.2±5.2
	MES-SA/DX5	100.0±0.0	83.7±0.8	35.9±12.6	24.3±7.9	18.2±6.6
Cell Counting (%)	MES-AS	100.0±0.0	91.0±1.6	79.5±3.2^*	65.1±6.6	50.3±6.3
	MES-SA/DX5	100.0±0.0	85.5±3.2	65.9±5.5	55.3±3.7	52.0±3.2
Annexin V +/PI − cells (%)	MES-AS	0.6±0.2	1.6±0.8	1.3±0.3	3.8±0.6	4.6±0.4
	MES-SA/DX5	2.9±0.9^*	3.9±1.0	3.1±0.2^*	5.1±0.9	4.9±0.3
Annexin V +/PI + cells (%)	MES-AS	1.1±0.10	1.5±0.26	3.2±0.60	5.6±0.76	9.0±1.77
	MES-SA/DX5	1.8±0.29	4.1±1.05^*	8.2±1.11^*	13.5±1.31^*	14.0±0.40^*

^(*)

denotes statistical significance between MES-SA and MES-SA/DX5 cells.